Working… Menu

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02533791
Recruitment Status : Completed
First Posted : August 27, 2015
Last Update Posted : October 14, 2015
Beijing Institute of Biotechnology
Tianjin Cansino Biotechnology Inc
Information provided by (Responsible Party):
Jiangsu Province Centers for Disease Control and Prevention